Metabolism News and Research

Latest Metabolism News and Research

First IVF embryo research licenses issued in Australia

Australia’s first licences allowing research using excess human embryos were issued today by the Embryo Research Licensing Committee of the National Health and Medical Research Council, (The NHMRC Licensing Committee).

17 Apr 2004

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals"

16 Apr 2004

Citrus soda culprit in patient’s medical mystery

It took a team of medical sleuths at Vanderbilt University Medical Center to get to the bottom of what was causing the 35-year-old to have abnormal blood chemistries during a post-transplant check up.

16 Apr 2004

Growth hormones combat Crohn’s disease, cardiac disorders and improve fertility in invitro fertilisation

New treatments for breast cancer, skin and wound healing and obesity will be revealed at an international conference in Cairns, Australia next week.

13 Apr 2004

DNA free radical damage research

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals," according to scientists at the National Institute of Standards and Technology (NIST) and National Institutes of Health (NIH). This type of damage has been implicated before in the development of prostate cancer, but the new research provides the first solid evidence that the normal repair process is altered in prostate cancer cells, possibly leading to a cascade of events that culminate in further DNA damage and cellular dysfunction.

9 Apr 2004

Cinacalet helps control overactive thyroids, a major complication of advanced kidney disease

A new drug can help control an overactive thyroid, a major complication of advanced kidney disease, by playing a trick on the gland, a new study finds. The drug, cinacalet, is much more effective at keeping the parathyroid gland working normally than a placebo, according to the study. It may be a good alternative to standard therapy, researchers said.

7 Apr 2004

Molecular analyses of leukemia patients suggest strategies for better treatments

The cure rate for pediatric acute lymphoblastic leukemia (ALL) might continue to rise with improved use of conventional therapies. But even more effective and less toxic therapies based on genetic and pharmacogenetic studies might one day push the success rate close to 100 percent, according to an article published by investigators at St. Jude Children’s Research Hospital in the April 8 issue of the New England Journal of Medicine.

7 Apr 2004

Hormone associated with obesity also plays a key role in male fertility

Researchers in the University of Warwick’s Department of Biological Sciences have found that a hormone associated with obesity is actually also very active in the male genitals where it plays a key role in male fertility and may even influence the erection response in male sexual arousal.

6 Apr 2004

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

New findings at the UCLA Neuropsychiatric Institute demonstrate the potential of a substance found in yohimbe tree bark to accelerate recovery from anxiety disorders suffered by millions of Americans.

4 Apr 2004

Gene of immune system linked to severe adverse drug reaction called Stevens-Johnson syndrome (SJS)

In a study of Han Chinese patients, researchers have for the first time directly linked a gene of the immune system to a severe adverse drug reaction called Stevens-Johnson syndrome (SJS), according to a Duke University Medical Center medical geneticist and collaborators in Taiwan.

1 Apr 2004

Sheffield University pioneers osteoporosis research

A leading osteoporosis expert from Sheffield has been awarded the prestigious Society for Endocrinology Medal and the Kohn Foundation Award for his 25-year commitment to revolutionising the treatment and diagnosis of osteoporosis.

31 Mar 2004

Removal of thyroid glands may be unnecessary for most patients

An unpleasant postoperative procedure for thyroid cancer patients who have had their thyroid glands surgically removed may be unnecessary for most patients, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.

30 Mar 2004

Thyroid disorders are often misdiagnosed

Thyroid disorders are among the most common medical conditions. However, because their symptoms often appear gradually, the condition is often misdiagnosed, according to Dr. Nila Vora, a board-certified endocrinologist at the Loyola Primary Care Center in Darien.

25 Mar 2004

20% of worldwide population lack enough zinc in diet

Up to one-fifth of the world's people lack sufficient zinc in their diet, while an estimated one-third live in countries considered at high risk of zinc deficiency, warns a comprehensive new report by an international group of medical researchers.

23 Mar 2004

Risk of kidney stones increases higher if overweight

Researchers at UT Southwestern Medical Center at Dallas have found that the more overweight a person is the more at risk he or she is for forming uric acid kidney stones.

22 Mar 2004

Research suggests the orlistat drug could be used to fight cancer and obesity

The Burnham Institute’s Jeffrey Smith, Ph.D., has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004

Side Effects of Diabetes Drugs Involve Unsuspected Brain Region

A brain region involved in emotional and intellectual processes appears to also play an unsuspected role in the body’s visceral response to dangerously low blood sugar levels, according to research at Washington University School of Medicine in St Louis. Low blood sugar, called hypoglycemia, is a common and dangerous side effect of drugs that control insulin levels in people with diabetes.

22 Mar 2004

Obesity Drug Inhibits Prostate Tumor Growth

The Burnham Institute's Jeffrey Smith, Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004

Metabolism News and Research

Latest Metabolism News and Research

First IVF embryo research licenses issued in Australia

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals"

Citrus soda culprit in patient’s medical mystery

Growth hormones combat Crohn’s disease, cardiac disorders and improve fertility in invitro fertilisation

DNA free radical damage research

Cinacalet helps control overactive thyroids, a major complication of advanced kidney disease

Molecular analyses of leukemia patients suggest strategies for better treatments

Hormone associated with obesity also plays a key role in male fertility

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

Gene of immune system linked to severe adverse drug reaction called Stevens-Johnson syndrome (SJS)

Sheffield University pioneers osteoporosis research

Removal of thyroid glands may be unnecessary for most patients

Thyroid disorders are often misdiagnosed

20% of worldwide population lack enough zinc in diet

Risk of kidney stones increases higher if overweight

Research suggests the orlistat drug could be used to fight cancer and obesity

Side Effects of Diabetes Drugs Involve Unsuspected Brain Region

Obesity Drug Inhibits Prostate Tumor Growth

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration